Opsonin Pharma Ltd (OPL) is a leading pharmaceutical company in Bangladesh, established in 1956. The company focuses on the development, manufacturing, and marketing of generic medicines for human use, aiming to improve the quality of life for individuals in Bangladesh and globally. Opsonin has built its reputation on providing quality medicines at affordable prices, offering 276 brands with 661 SKUs as pharmaceutical finished products, along with animal health and consumer products. The company's commitment to contributing to the national healthcare sector and strengthening its global presence is evident through its modern machinery and highly qualified professionals. Opsonin Pharma Ltd is positioned as a provider of value-added products that support longer, healthier, and more productive lives. The company's dedication to continuous improvement underscores its ambition to be a leading pharmaceutical company in Bangladesh and expand its global footprint. With its expertise in biotechnology, manufacturing, and pharmaceuticals, Opsonin is on a trajectory to enhance its position in the industry and contribute significantly to global healthcare.
There is no investment information
No recent news or press coverage available for Opsonin Pharma Ltd.